BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
DNA fingerprint
,
Rapamycin
,
rs2476601
,
FOXP1
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
barrier blood- testes
Summary
General Info
Curated Studies
Most Correlated Studies
Cerebrocortical cells treated with blood-brain barrier penetrant clinic-tested drugs
Basophils anergic or reactive stimulated with anti-FCER1A antibodies
T cells activated in microgravity compared to 1g Earth's full gravity
Cecal CD45+ cells from serrated polyps or surrounding tissue of intestinal HBEGF overexpressing mice
Brain microvascular endothelial cells treated with PKC-beta inhibitor, LY317615
Explore Curated Studies Results
Literature
Most Relevant Literature
Cross-talk between Vimentin and autophagy regulates blood-testis barrier disruption induced by cadmi…
Drug Transporters at the Human Blood-Testis Barrier.
HDAC3 promotes Sertoli cell maturation and maintains the blood-testis barrier dynamics.
Inhibition of miR-143-3p Restores Blood-Testis Barrier Function and Ameliorates Sertoli Cell Senesce…
In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CMV IGG Antibodies in Semen as a Predictor for Blood Testis Barrier Damage
Semen Analysis Changes in Covid-19 Positivepatients
PET Imaging of P-glycoprotein Function Using [11C]dLop
Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ…
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed o…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ